The LNG-IUS, the levonorgestrel-releasing intrauterine system (commercially marketed as Mirena®, is a highly effective form of long-acting, reversible contraception. It is growing in popularity in Europe and North America and has the potential to contribute to IUD programs worldwide. This section includes information on:
This document presents an overview of key biomedical, social science, and programmatic knowledge about the levonorgestrel-releasing intrauterine system (LNG-IUS) as of January 2009.
View individual sections of the document:
This peer-reviewed brief gives an overview of the levonorgestrel intrauterine system (LNG-IUS), including effectiveness, safety, benefits, current program use, and information about the manufacturer, registration status, and costs. The goal is to improve information about underused contraceptive methods to improve women's and couple's access to a range of family planning methods.
This patient information leaflet was developed by the ICA Foundation. It provides an overview of the LNG-IUS to potential users, and includes information about side effects, insertion and removal procedures, mechanism of action, and efficacy.
This provider information leaflet was developed by the ICA Foundation. It provides a technical overview of the LNG-IUS for providers, and includes information about the following: product description, active ingredient, mechanism of action, method acceptors, insertion procedure, patient counseling, effectiveness, conditions requiring precautions, side effects, benefits and limitations to LNG-IUS use.
This technical brief was developed by members of the Caucus on New and Underused Reproductive Health Technologies, a thematic group established under the auspices of the Reproductive Health Supplies Coalition. One in a series of ten, this brief focuses on the levonorgestrel intrauterine system (LNG-IUS). It provides a basic description of the LNG-IUS, as well as information on efficacy, current program/sector use, manufacturing, registration, and pricing.
This document provides a brief overview of key similarities and differences between the levonorgestrel-releasing intrauterine system (LNG-IUS) and the copper-bearing Copper-T 380 IUD (TCu-380A).
2007 | World Health Organization Department of Reproductive Health and Research and Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs
Family Planning: A Global Handbook for Providers, offers clinic-based health care professionals in developing countries the latest guidance on providing contraceptive methods. Primary features of the handbook include:
This document reviews the medical eligibility criteria for use of contraception, offering guidance on the safety of different methods for women and men with specific characteristics or known medical conditions.